Dendreon Corp fka DNDNQ

[walldiver]

It's all water under the bridge now...but for Dr. No to succeed, he needs some willing tools. There also may have been more than meets the eye on the company's side of things. Not having any discussions with the FDA after the positive advisory panel vote strikes me as odd (no labeling discussions, no post-approval 9902B discussions?), and perhaps it means that CBER never was going to approve Provenge on this go-round. What other issues were going on behind the scenes that we'll never know about?